The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Christopher H. Goss

Department of Medicine

University of Washington

Seattle

USA

[email]@u.washington.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine, University of Washington, Seattle, USA. 2002 - 2009
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington Medical Center, Campus Box 356522, USA. 2002 - 2007
  • University of Washington Medical Center, Campus Box 356522, 1959 N.E. Pacific, Seattle, USA. 2006

References

  1. Patient-reported respiratory symptoms in cystic fibrosis. Goss, C.H., Edwards, T.C., Ramsey, B.W., Aitken, M.L., Patrick, D.L. J. Cyst. Fibros. (2009) [Pubmed]
  2. Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate cystic fibrosis. Goss, C.H., McKone, E.F., Mathews, D., Kerr, D., Wanger, J.S., Millard, S.P. J. Cyst. Fibros. (2008) [Pubmed]
  3. Patient-reported outcomes in cystic fibrosis. Goss, C.H., Quittner, A.L. Proc. Am. Thorac. Soc (2007) [Pubmed]
  4. Laboratory parameter profiles among patients with cystic fibrosis. Goss, C.H., Mayer-Hamblett, N., Kronmal, R.A., Williams, J., Ramsey, B.W. J. Cyst. Fibros. (2007) [Pubmed]
  5. Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Goss, C.H., Burns, J.L. Thorax (2007) [Pubmed]
  6. Clinical trial participants compared with nonparticipants in cystic fibrosis. Goss, C.H., Rubenfeld, G.D., Ramsey, B.W., Aitken, M.L. Am. J. Respir. Crit. Care Med. (2006) [Pubmed]
  7. Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Goss, C.H., Newsom, S.A., Schildcrout, J.S., Sheppard, L., Kaufman, J.D. Am. J. Respir. Crit. Care Med. (2004) [Pubmed]
  8. Update on cystic fibrosis epidemiology. Goss, C.H., Rosenfeld, M. Curr. Opin. Pulm. Med (2004) [Pubmed]
  9. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Goss, C.H., Mayer-Hamblett, N., Aitken, M.L., Rubenfeld, G.D., Ramsey, B.W. Thorax (2004) [Pubmed]
  10. The effect of pregnancy on survival in women with cystic fibrosis. Goss, C.H., Rubenfeld, G.D., Otto, K., Aitken, M.L. Chest (2003) [Pubmed]
  11. Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital. Goss, C.H., Rubenfeld, G.D., Park, D.R., Sherbin, V.L., Goodman, M.S., Root, R.K. Chest (2003) [Pubmed]
  12. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Goss, C.H., Otto, K., Aitken, M.L., Rubenfeld, G.D. Am. J. Respir. Crit. Care Med. (2002) [Pubmed]
  13. The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases. Goss, C.H., Mayer-Hamblett, N., Kronmal, R.A., Ramsey, B.W. Adv. Drug Deliv. Rev. (2002) [Pubmed]
 
WikiGenes - Universities